Back to Browse Journals » Transplant Research and Risk Management » Volume 1 » Default

Managing hepatitis C in liver transplant patients with recurrent infection

Authors Tim Zimmermann, Gerd Otto, Marcus Schuchmann

Published Date September 2009 Volume 2009:1(Default) Pages 1—14

DOI http://dx.doi.org/10.2147/TRRM.S4615

Published 13 September 2009

Tim Zimmermann1, Gerd Otto2, Marcus Schuchmann1

1Department of Internal Medicine, 2Transplantation Surgery, University of Mainz, Germany

Abstract: Hepatitis C virus (HCV) reinfection after liver transplantation (LT) and recurrent hepatitis C often lead to recurrent cirrhosis (RC). RC is one of the most frequent complications resulting in organ failure and early death after LT in HCV-positive patients with reported 5-year rates from 20% to 40%. As HCV-cirrhosis is one of the leading indications for LT, the therapeutic management is a central issue. To date, the best available therapy is a combination of pegylated interferon + ribavirin in patients with established recurrent hepatitis C proven by liver biopsy. Although increasing experience in using interferon therapy after LT has suggested better response rates, treatment is limited by a poor tolerability and high rates of severe side effects, necessitating lower doses or withdrawal of therapy. The extent to which dose reductions and the concomitant administration of growth factors affect virological response or prevent complications is still to be determined. Prospective clinical trials are mandatory to identify the best time point and schedule of antiviral treatment in transplant patients. Currently, therapeutic options need to be discussed for each individual patient. Therefore therapy should be carried out only in transplant centers with experience in managing hepatitis C after LT.

Keywords: hepatitis C, liver transplantation, recurrent infection, treatment

Download Article [PDF] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Readers of this article also read:

Distal femoral opening-wedge osteotomy for lateral compartment osteoarthritis of the knee

Dirk HPW Das, Thea Sijbesma, Henk J Hoekstra, Willem M van Leeuwen

Open Access Surgery 2008, 1:25-29

Published Date: 10 November 2008

Problems and barriers of pain management in the emergency department: Are we ever going to get better?

Sergey M Motov, Abu NGA Khan

Journal of Pain Research 2009, 2:5-11

Published Date: 9 December 2008

Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors

Eduardo Pimenta, Suzanne Oparil

Vascular Health and Risk Management 2009, 5:453-463

Published Date: 19 May 2009

Neurotransmitter testing of the urine: a comprehensive analysis

Marty Hinz, Alvin Stein, George Trachte, et al

Research and Reports in Urology 2010, 2:177-183

Published Date: 7 October 2010

Everolimus in kidney transplantation

Cooper JE, Christians U, Wiseman AC

Transplant Research and Risk Management 2011, 3:97-112

Published Date: 8 July 2011

Facial transplantation: a review of ethics, progress, and future targets

Edwards JA, Mathes DW

Transplant Research and Risk Management 2011, 3:113-125

Published Date: 5 September 2011

Stem cells: a model for screening, discovery and development of drugs

Kitambi SS, Chandrasekar G

Stem Cells and Cloning: Advances and Applications 2011, 4:51-59

Published Date: 27 September 2011

Drug-resistant tuberculosis: emerging treatment options

Adhvaryu MR, Vakharia BC

Clinical Pharmacology: Advances and Applications 2011, 3:51-67

Published Date: 14 December 2011